131 related articles for article (PubMed ID: 25536612)
1. Efficacy of stereotactic radiotherapy as salvage treatment for recurrent malignant gliomas.
Ekici K; Ozseker N; Mayadagli A; Erdogan Kocak M; Olmezoglu A
J BUON; 2014; 19(4):1029-34. PubMed ID: 25536612
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife.
Adachi K; Hayashi K; Kagawa N; Kinoshita M; Sumida I; Akino Y; Shiomi H; Tamari K; Suzuki O; Hirayama R; Kijima N; Isohashi F; Seo Y; Otani K; Kishima H; Ogawa K
Anticancer Res; 2019 Jun; 39(6):2935-2940. PubMed ID: 31177132
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.
Yaprak G; Isık N; Gemici C; Pekyurek M; Ceylaner Bıcakcı B; Demircioglu F; Tatarlı N
Stereotact Funct Neurosurg; 2020; 98(3):167-175. PubMed ID: 32248188
[TBL] [Abstract][Full Text] [Related]
4. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
6. Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control.
Miyakawa A; Shibamoto Y; Takemoto S; Serizawa T; Otsuka S; Hirai T
Int J Clin Oncol; 2017 Apr; 22(2):250-256. PubMed ID: 27826659
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Stereotactic Radiotherapy and Bevacizumab for Recurrent High-Grade Gliomas: A Potential Therapy for Isocitrate Dehydrogenase Wild-Type Recurrent High-Grade Gliomas.
Yasuda T; Muragaki Y; Nitta M; Miyamoto K; Oura Y; Henmi T; Noguchi S; Oda H; Saito T; Maruyama T; Atsuchi S; Miura N; Kawamata T
World Neurosurg; 2018 Jun; 114():e1138-e1146. PubMed ID: 29614360
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.
McKenzie JT; Guarnaschelli JN; Vagal AS; Warnick RE; Breneman JC
J Neurooncol; 2013 Jul; 113(3):403-9. PubMed ID: 23589034
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.
Kong DS; Lee JI; Park K; Kim JH; Lim DH; Nam DH
Cancer; 2008 May; 112(9):2046-51. PubMed ID: 18338759
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.
Shepherd SF; Laing RW; Cosgrove VP; Warrington AP; Hines F; Ashley SE; Brada M
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):393-8. PubMed ID: 9069312
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control.
Ogura K; Mizowaki T; Arakawa Y; Sakanaka K; Miyamoto S; Hiraoka M
Cancer Med; 2013 Dec; 2(6):942-9. PubMed ID: 24403268
[TBL] [Abstract][Full Text] [Related]
12. Salvage stereotactic radiosurgery for recurrent gliomas with prior radiation therapy.
Sutera PA; Bernard ME; Gill BS; Quan K; Engh JA; Burton SA; Heron DE
Future Oncol; 2017 Dec; 13(29):2681-2690. PubMed ID: 29198146
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study).
Laing RW; Warrington AP; Graham J; Britton J; Hines F; Brada M
Radiother Oncol; 1993 Apr; 27(1):22-9. PubMed ID: 8327729
[TBL] [Abstract][Full Text] [Related]
14. Salvage Leksell Stereotactic Radiosurgery for Malignant Gliomas.
Niranjan A; Kano H; Monaco Iii EA; Lunsford LD
Prog Neurol Surg; 2019; 34():191-199. PubMed ID: 31096255
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.
Fogh SE; Andrews DW; Glass J; Curran W; Glass C; Champ C; Evans JJ; Hyslop T; Pequignot E; Downes B; Comber E; Maltenfort M; Dicker AP; Werner-Wasik M
J Clin Oncol; 2010 Jun; 28(18):3048-53. PubMed ID: 20479391
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience.
Guan Y; Xiong J; Pan M; Shi W; Li J; Zhu H; Gong X; Li C; Mei G; Liu X; Pan L; Dai J; Wang Y; Wang E; Wang X
BMC Cancer; 2021 Feb; 21(1):123. PubMed ID: 33546642
[TBL] [Abstract][Full Text] [Related]
17. Fractionated stereotactic radiosurgery with volumetric modulated arc therapy (Rapid Arc) for reradiation in recurrent high grade gliomas.
Anand AK; Kumar P; Patir R; Vaishya S; Bansal AK; Chaudhoory AR; Punnakal AU; Malhotra H; Munjal RK
J Cancer Res Ther; 2014; 10(1):97-102. PubMed ID: 24762494
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation of gliomas under stereotactic conditions: Prognostic factors for survival without relapse or side effects, a retrospective study at Tours regional university hospital (France).
Lévy S; Chapet S; Scher N; Debbi K; Ruffier A; Bernadou G; Pointreau Y; Calais G
Cancer Radiother; 2017 Dec; 21(8):759-765. PubMed ID: 29128197
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.
Marcus KJ; Goumnerova L; Billett AL; Lavally B; Scott RM; Bishop K; Xu R; Young Poussaint T; Kieran M; Kooy H; Pomeroy SL; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):374-9. PubMed ID: 15667955
[TBL] [Abstract][Full Text] [Related]
20. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.
Shi W; Blomain ES; Siglin J; Palmer JD; Dan T; Wang Y; Werner-Wasik M; Glass J; Kim L; Bar Ad V; Bhamidipati D; Evans JJ; Judy K; Farrell CJ; Andrews DW
J Neurooncol; 2018 Mar; 137(1):171-177. PubMed ID: 29235052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
